Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-09-057259
Filing Date
2009-12-16
Accepted
2009-12-16 12:48:26
Documents
1
Period of Report
2009-12-14

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c93775_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c93775_4x0.xml 4 6575
  Complete submission text file 0001209191-09-057259.txt   8271
Mailing Address
Business Address
KARABELAS ARGERIS N (Reporting) CIK: 0001191229 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34186 | Film No.: 091243915

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850 240-599-4500
Vanda Pharmaceuticals Inc. (Issuer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations